My EXACTLY plan to buy Palantir Stock
1 extracted signal · 1 resolved · 0 still active
Traders Helping TradersIndependent analyst profile- Source published
- 23 Jul 2026, 20:30 UTC
- Recorded by Tahlil Plus
- 23 Jul 2026, 20:59 UTC

AI-generated source summary
The analysis focuses on Palantir (PLTR) and its market cycle. The speaker has been bearish on PLTR since February 2026, awaiting a pullback. The current price is $121.87, and the speaker anticipates a potential drop to the $100-$90 range, aligning with the monthly fair value band, which is identified as a resistance level. The fail bound for this bearish prediction is set at $150. The speaker explains that institutional investors typically sell into retail buying at all-time highs, and when price breaks below the short-term bullish cycle, it enters a redistribution phase, trading below the monthly fair value band. The analyst believes this redistribution phase can last one to two years before a new bull cycle begins. The current chart indicates PLTR is in this redistribution phase, having bounced off a resistance level and showing signs of further decline.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Traders Helping Traders
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
